1. Home
  2. QUAD vs BNR Comparison

QUAD vs BNR Comparison

Compare QUAD & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quad Graphics Inc

QUAD

Quad Graphics Inc

HOLD

Current Price

$7.06

Market Cap

305.8M

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$23.46

Market Cap

322.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUAD
BNR
Founded
1971
2014
Country
United States
China
Employees
N/A
N/A
Industry
Publishing
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
305.8M
322.1M
IPO Year
2010
2019

Fundamental Metrics

Financial Performance
Metric
QUAD
BNR
Price
$7.06
$23.46
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$9.90
N/A
AVG Volume (30 Days)
199.1K
11.2K
Earning Date
05-20-2026
01-01-0001
Dividend Yield
5.40%
N/A
EPS Growth
150.47
N/A
EPS
0.54
N/A
Revenue
$2,419,900,000.00
N/A
Revenue This Year
N/A
$136.32
Revenue Next Year
N/A
N/A
P/E Ratio
$13.75
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.50
$2.18
52 Week High
$7.54
$41.72

Technical Indicators

Market Signals
Indicator
QUAD
BNR
Relative Strength Index (RSI) 61.44 37.68
Support Level $5.23 $7.99
Resistance Level N/A $24.23
Average True Range (ATR) 0.37 1.82
MACD 0.08 -1.13
Stochastic Oscillator 69.74 5.17

Price Performance

Historical Comparison
QUAD
BNR

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America and others countries. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market..

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: